rs702859

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002240.5(KCNJ6):​c.1032C>T​(p.Asp344Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.686 in 1,613,624 control chromosomes in the GnomAD database, including 382,389 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 40429 hom., cov: 32)
Exomes 𝑓: 0.68 ( 341960 hom. )

Consequence

KCNJ6
NM_002240.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.344

Publications

33 publications found
Variant links:
Genes affected
KCNJ6 (HGNC:6267): (potassium inwardly rectifying channel subfamily J member 6) This gene encodes a member of the G protein-coupled inwardly-rectifying potassium channel family of inward rectifier potassium channels. This type of potassium channel allows a greater flow of potassium into the cell than out of it. These proteins modulate many physiological processes, including heart rate in cardiac cells and circuit activity in neuronal cells, through G-protein coupled receptor stimulation. Mutations in this gene are associated with Keppen-Lubinsky Syndrome, a rare condition characterized by severe developmental delay, facial dysmorphism, and intellectual disability. [provided by RefSeq, Apr 2015]
KCNJ6-AS1 (HGNC:41352): (KCNJ6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 21-37625399-G-A is Benign according to our data. Variant chr21-37625399-G-A is described in ClinVar as Benign. ClinVar VariationId is 1170806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.344 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.849 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNJ6NM_002240.5 linkc.1032C>T p.Asp344Asp synonymous_variant Exon 4 of 4 ENST00000609713.2 NP_002231.1 P48051
KCNJ6-AS1NR_183540.1 linkn.408-73156G>A intron_variant Intron 1 of 7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNJ6ENST00000609713.2 linkc.1032C>T p.Asp344Asp synonymous_variant Exon 4 of 4 1 NM_002240.5 ENSP00000477437.1 P48051
KCNJ6ENST00000645093.1 linkc.1032C>T p.Asp344Asp synonymous_variant Exon 5 of 5 ENSP00000493772.1 P48051
ENSG00000286717ENST00000667151.1 linkn.161-21148G>A intron_variant Intron 1 of 2
ENSG00000286717ENST00000838658.1 linkn.234+31263G>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.725
AC:
110211
AN:
152004
Hom.:
40392
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.801
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.775
Gnomad ASJ
AF:
0.698
Gnomad EAS
AF:
0.870
Gnomad SAS
AF:
0.663
Gnomad FIN
AF:
0.634
Gnomad MID
AF:
0.703
Gnomad NFE
AF:
0.680
Gnomad OTH
AF:
0.719
GnomAD2 exomes
AF:
0.711
AC:
177216
AN:
249130
AF XY:
0.702
show subpopulations
Gnomad AFR exome
AF:
0.800
Gnomad AMR exome
AF:
0.799
Gnomad ASJ exome
AF:
0.695
Gnomad EAS exome
AF:
0.870
Gnomad FIN exome
AF:
0.633
Gnomad NFE exome
AF:
0.680
Gnomad OTH exome
AF:
0.691
GnomAD4 exome
AF:
0.682
AC:
996864
AN:
1461502
Hom.:
341960
Cov.:
47
AF XY:
0.681
AC XY:
495089
AN XY:
727094
show subpopulations
African (AFR)
AF:
0.806
AC:
26963
AN:
33470
American (AMR)
AF:
0.798
AC:
35697
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.692
AC:
18091
AN:
26130
East Asian (EAS)
AF:
0.888
AC:
35242
AN:
39698
South Asian (SAS)
AF:
0.650
AC:
56023
AN:
86252
European-Finnish (FIN)
AF:
0.633
AC:
33803
AN:
53420
Middle Eastern (MID)
AF:
0.646
AC:
3724
AN:
5768
European-Non Finnish (NFE)
AF:
0.671
AC:
745440
AN:
1111652
Other (OTH)
AF:
0.694
AC:
41881
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
17289
34578
51867
69156
86445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19320
38640
57960
77280
96600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.725
AC:
110299
AN:
152122
Hom.:
40429
Cov.:
32
AF XY:
0.723
AC XY:
53762
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.801
AC:
33263
AN:
41520
American (AMR)
AF:
0.775
AC:
11855
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.698
AC:
2421
AN:
3470
East Asian (EAS)
AF:
0.870
AC:
4488
AN:
5160
South Asian (SAS)
AF:
0.662
AC:
3191
AN:
4820
European-Finnish (FIN)
AF:
0.634
AC:
6702
AN:
10570
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.680
AC:
46201
AN:
67972
Other (OTH)
AF:
0.722
AC:
1524
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1549
3098
4647
6196
7745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.699
Hom.:
85252
Bravo
AF:
0.738
Asia WGS
AF:
0.810
AC:
2813
AN:
3478
EpiCase
AF:
0.680
EpiControl
AF:
0.670

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Keppen-Lubinsky syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.65
DANN
Benign
0.49
PhyloP100
-0.34
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs702859; hg19: chr21-38997701; COSMIC: COSV108050505; API